ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Viva Biotech and SYNthesis Enter Strategic Acquisition Agreement
September 22, 2020Accelerates Viva’s development of global innovative drug R&D service capabilities. -
Viva Biotech and SYNthesis Enters a Strategic Acquisition Agreement, Accelerating the Development of Global Innovative Drug R & D Service Capabilities
September 21, 2020Viva Biotech (Shanghai) Co., Ltd. entered into the Share Purchase Agreement pursuant to which Viva Biotech agreed to acquire and the Vendors agreed to collectively sell 100% of the equity interest in SYNthesis med chem (Hong Kong, S.A.R., China) Limited . -
Eurofins Genomics US Expands Gene Synthesis Capabilities
August 12, 2019Acquires Blue Heron Biotech, known for expertise in gene synthesis and sub cloning ...
Pharma Sources Insight January 2025
